Article
MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy.
Clinical chemistry and laboratory medicine - 23 Feb 2018
Yuan Fang, Qiu Zhao-Hui, Wang Xing-Hua, Sun Yu-Min, Wang Jun, Li Ruo-Gu, Liu Hua, Zhang Min, Shi Hong-Yu, Zhao Liang, Jiang Wei-Feng, Liu Xu, Qiu Xing-Biao, Qu Xin-Kai, Yang Yi-Qing
Abstract excerpt
BACKGROUND: The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). However, in humans, the association of MEF2C variation with DCM remains to be investigated. METHODS: The coding regions and splicing boundaries of the MEF2C gene were sequenced in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
